» Articles » PMID: 37503500

The New Stealth Drug on the Street: A Narrative Review of Xylazine As a Street Drug

Overview
Journal Cureus
Date 2023 Jul 28
PMID 37503500
Authors
Affiliations
Soon will be listed here.
Abstract

Xylazine is an alpha-adrenergic receptor agonist approved for use only in animals with a prescription from a veterinarian. It is a powerful sedative that is slowly infiltrating the recreational street drug scene and is often used by polysubstance abusers. Known as "tranq," it can be fatal, and xylazine-induced toxicity cannot be reversed with naloxone or nalmefene. Due to its vasoconstrictive effects, chronic use of xylazine is associated with necrotic skin lesions and general deterioration of health. Since xylazine is not approved for human use and is not scheduled as a controlled substance, there are no human studies to provide evidence of drug-drug interactions, lethal doses, or reversal protocols. Xylazine is available online without a prescription. Street drug users may take xylazine knowingly or unknowingly, as it is often combined with other illicit substances such as fentanyl. There are no rapid tests for xylazine, although there are specialty tests that can be ordered. Xylazine represents a major threat to street drug users and another challenge to emergency healthcare workers, first responders, and others who care for those who have taken this "new" street drug.

Citing Articles

ENA-001 Reverses Xylazine/Fentanyl Combination-Induced Respiratory Depression in Rats: A Qualitative Pilot Study.

Miller T, Mathews J, Dungan G, Pergolizzi J, Raffa R Cureus. 2024; 16(11):e74826.

PMID: 39618763 PMC: 11608063. DOI: 10.7759/cureus.74826.


An Amperometric Sensor with Anti-Fouling Properties for Indicating Xylazine Adulterant in Beverages.

Vinnikov A, Sheppard C, Wemple A, Stern J, Leopold M Micromachines (Basel). 2024; 15(11).

PMID: 39597161 PMC: 11596286. DOI: 10.3390/mi15111340.


Fouling-Resistant Voltammetric Xylazine Sensors for Detection of the Street Drug "Tranq".

Stern J, Wemple A, Sheppard C, Vinnikov A, Leopold M Toxics. 2024; 12(11).

PMID: 39590971 PMC: 11598047. DOI: 10.3390/toxics12110791.


Mucocutaneous Manifestations of Recreational Drug Use.

Alexander-Savino C, Mirowski G, Culton D Am J Clin Dermatol. 2024; 25(2):281-297.

PMID: 38217568 DOI: 10.1007/s40257-023-00835-y.


Clinical Use of Adrenergic Receptor Ligands in Acute Care Settings.

Langnas E, Maze M Handb Exp Pharmacol. 2024; 285:617-637.

PMID: 38177400 DOI: 10.1007/164_2023_705.


References
1.
Malayala S, Papudesi B, Bobb R, Wimbush A . Xylazine-Induced Skin Ulcers in a Person Who Injects Drugs in Philadelphia, Pennsylvania, USA. Cureus. 2022; 14(8):e28160. PMC: 9482722. DOI: 10.7759/cureus.28160. View

2.
Liu C, Chiu M, Fang C, Chen W . Xylazine abuse: a rare cause of syncope. Clin Toxicol (Phila). 2007; 45(3):309-11. DOI: 10.1080/15563650601073520. View

3.
Alexander R, Canver B, Sue K, Morford K . Xylazine and Overdoses: Trends, Concerns, and Recommendations. Am J Public Health. 2022; 112(8):1212-1216. PMC: 9342814. DOI: 10.2105/AJPH.2022.306881. View

4.
Ball N, Knable B, Relich T, Smathers A, Gionfriddo M, Nemecek B . Xylazine poisoning: a systematic review. Clin Toxicol (Phila). 2022; 60(8):892-901. DOI: 10.1080/15563650.2022.2063135. View

5.
Zhu L, Han X, Zhu J, Du L, Liu L, Gong W . Severe acute intoxication with yohimbine: Four simultaneous poisoning cases. Forensic Sci Int. 2021; 320:110705. DOI: 10.1016/j.forsciint.2021.110705. View